Practical Information & FAQ's

All you need to know about Vaccine Virtual Days 2024 Join the conversation via #VaccineVirtualDays

Frequently Asked Questions

How do I register for the event?
To register please click HERE >

What are the live dates of the event?
23-26 April 2024. Please note each day will focus on a different part of the world and will go live at different times depending on time zones. For detailed timings and sessions please see the agenda pages >

How do I access the live event?
The event is fully virtual. The link to access the virtual platform where the event will be hosted, will be emailed to you an hour before the scheduled start time (to the same email address you have registered with). Please check your spam/filtered inbox.

What languages will the event be in?
Live event will be available in English and Spanish.

How do I obtain a certificate of attendance?
CPD credits will be granted for this event. You will be able to download a certificate of attendance for each session upon attending session on the platform. Please note that depending on your country regulations you may not be able to participate in each session.

Will the recording be available post event?
Yes, the session recordings will be made available on the event platform post live event. Please note the on demand service will only run for three months post event.

What are the adverse events reporting procedures?
All Healthcare Professionals are required to follow their country specific legal requirements and local guidelines for the reporting of adverse events.

Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products via adr@afmps.be or via www.notifieruneffetindesirable.be or to GlaxoSmithKline Pharmaceuticals s.a./n.v. via be.medinfo@gsk.com.

UK: Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0) 800 221 441 or UKSafety@gsk.com.

Other countries: Please follow https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/

Privacy Notice | Terms of Use

Privacy Notice Summary
GSK makes every effort to ensure any data you provide is held securely. We will use your data to register you for the event and get your feedback on the quality of the sessions. We will share registrant and attendance information with GSK staff which may include GSK authorised organisers of the event in your country.

April 2024 | NX-GBL-GVU-AGND-240001